The forecasted sales values (in Billion Pounds Sterling) for Alimentary Tract and Metabolism Medicines from 2024 to 2028 are as follows:
- 2024: 2.2
- 2025: 2.24
- 2026: 2.28
- 2027: 2.32
- 2028: 2.36
Year-on-Year Variation in Percentage:
- 2024-2025: 1.82%
- 2025-2026: 1.79%
- 2026-2027: 1.75%
- 2027-2028: 1.72%
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 1.77%.
Future trends to monitor include advancements in pharmaceutical technology, an aging population, and rising incidences of gastrointestinal and metabolic disorders. Additionally, regulatory changes and the economic environment will also play crucial roles in shaping the market. Strategic investment in R&D and personalized medicine approaches could offer significant growth opportunities in the sector.
